AbCellera Biologics (ABCL) Capital Expenditures (2020 - 2026)
AbCellera Biologics' Capital Expenditures came in at $2.13 million for Q2 2026, down 84.0% from $13.37 million a year earlier and down 44.3% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Capital Expenditures (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, AbCellera Biologics reported Capital Expenditures of $24.73 million, down 57.5% year-over-year; for FY2025, it came in at $42.77 million, down 45.4% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of 34.6% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $78.4 million in FY2024 (+1.9%), $76.95 million in FY2023 (+8.9%), $70.66 million in FY2022 (+20.9%) and $58.45 million in FY2021 (+504.3%).
- The Q2 2026 figure represents the lowest quarterly Capital Expenditures since Q4 2020.
- Year-over-year, Capital Expenditures has declined for six consecutive quarters, with an average decline of 40.9% over the last eight quarters.
- The fastest year-over-year change in Capital Expenditures over five years came in Q4 2021 (growth of 527.8%), and the weakest in Q2 2026 (a decline of 84.0%).
- Business Quant data shows ABCL's Capital Expenditures at $3.83 million (Q1 2026), $9.84 million (Q4 2025) and $8.93 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 112.20 Mn |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - | 2.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.13 Mn |
| Mar 31, 2026 | 3.83 Mn |
| Dec 31, 2025 | 9.84 Mn |
| Sep 30, 2025 | 8.93 Mn |
| Jun 30, 2025 | 13.37 Mn |
| Mar 31, 2025 | 10.64 Mn |
| Dec 31, 2024 | 15.63 Mn |
| Sep 30, 2024 | 18.52 Mn |
| Jun 30, 2024 | 20.11 Mn |
| Mar 31, 2024 | 24.14 Mn |
| Dec 31, 2023 | 14.43 Mn |
| Sep 30, 2023 | 20.33 Mn |
| Jun 30, 2023 | 27.20 Mn |
| Mar 31, 2023 | 14.98 Mn |
| Dec 31, 2022 | 12.33 Mn |
| Sep 30, 2022 | 12.51 Mn |
| Jun 30, 2022 | 31.32 Mn |
| Mar 31, 2022 | 14.50 Mn |
| Dec 31, 2021 | 9.43 Mn |
| Sep 30, 2021 | 8.57 Mn |
API Access
AbCellera Biologics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();